Literature DB >> 11458965

Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus.

T D Rea1, J E Russo, W Katon, R L Ashley, D S Buchwald.   

Abstract

BACKGROUND: Knowledge regarding the clinical characteristics and natural history of acute infectious mononucleosis is based largely on older, often retrospective, studies without systematic follow-up. Differences in diagnosis, methodology, or treatment between historical and current practice might affect an understanding of this illness.
METHODS: Using a prospective case series design, we enrolled 150 persons with an acute illness serologically confirmed as Epstein-Barr virus infection. The goal of the study was to assess symptoms, physical examination findings, laboratory tests, and functional status measures during the acute presentation and 1, 2, and 6 months later.
RESULTS: Acutely, infectious mononucleosis was characterized by the symptoms of sore throat and fatigue and substantial functional impairment. Objective physical and laboratory examination findings included pharyngitis and cervical lymphadenopathy, a moderate absolute and atypical lymphocytosis, and mildly elevated transaminase levels. The traditional signs of fever and splenomegaly were relatively uncommon. By 1 month, most symptoms and signs and all laboratory tests had returned to normal. Fatigue, cervical lymphadenopathy, pharyngitis, and functional health status improved more slowly.
CONCLUSIONS: In contemporary practice most of the classical illness features of infectious mononucleosis are observed. Symptoms, signs, and poor functioning might be protracted in some patients.

Entities:  

Mesh:

Year:  2001        PMID: 11458965

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  26 in total

1.  Alterations in immune function are associated with liver enzyme elevation in HIV and HCV co-infection after commencement of combination antiretroviral therapy.

Authors:  Barbara Anne Cameron; Carol R Emerson; Cassy Workman; Mark D Kelly; Andrew R Lloyd; Jeffrey J Post
Journal:  J Clin Immunol       Date:  2011-09-20       Impact factor: 8.317

Review 2.  Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.

Authors:  Bridget Candy; Trudie Chalder; Anthony J Cleare; Simon Wessely; Peter D White; Matthew Hotopf
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 3.  Mild infectious mononucleosis presenting with transient mixed liver disease: case report with a literature review.

Authors:  David Lawee
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

4.  Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Authors:  Jeffrey I Cohen; Lesia Dropulic; Amy P Hsu; Christa S Zerbe; Tammy Krogmann; Kennichi Dowdell; Ronald L Hornung; Jana Lovell; Nancy Hardy; Dennis Hickstein; Edward W Cowen; Katherine R Calvo; Stefania Pittaluga; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-05-11       Impact factor: 9.079

5.  Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Authors:  Shalyn C Clute; Levi B Watkin; Markus Cornberg; Yuri N Naumov; John L Sullivan; Katherine Luzuriaga; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 6.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.

Authors:  Marika Valota; Friedrich Thienemann; Benjamin Misselwitz
Journal:  BMJ Case Rep       Date:  2019-05-10

8.  Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection.

Authors:  S Zidovec Lepej; A Vince; O Dakovic Rode; A Remenar; T Jeren
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.

Authors:  Heather E Vezina; Henry H Balfour; Dennis R Weller; Bruce J Anderson; Richard C Brundage
Journal:  J Clin Pharmacol       Date:  2009-11-06       Impact factor: 3.126

10.  Association of Splenic Rupture and Infectious Mononucleosis: A Retrospective Analysis and Review of Return-to-Play Recommendations.

Authors:  Jillian E Sylvester; Benjamin K Buchanan; Scott L Paradise; Joshua J Yauger; Anthony I Beutler
Journal:  Sports Health       Date:  2019-09-24       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.